Reply to A. Pfob and C. Sidey-Gibbons

Carlos H Barcenas¹, Juhee Song, Rashmi K Murthy¹, Akshara S Raghavendra¹, Yisheng Li¹, Limin Hsu¹, Robert W Carlson¹, Debu Tripathy¹, Gabriel N Hortobagyi¹

Affiliations

Affiliation

¹ Carlos H. Barcenas, MD, MS, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; Juhee Song, PhD, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX; Rashmi K. Murthy, MD, MBE and Akshara S. Raghavendra, MD, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; Yisheng Li, PhD, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX; Limin Hsu, MS, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; Robert W. Carlson, MD, National Comprehensive Cancer Network (NCCN), Plymouth Meeting, PA, Department of Medicine, Division of Medical Oncology, Stanford University Medical Center, Stanford, CA; and Debu Tripathy, MD and Gabriel N. Hortobagyi, MD, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

PMID: 35175860
DOI: 10.1200/CCI.21.00171

Comment

Reply to A. Pfob and C. Sidey-Gibbons

Carlos H Barcenas et al. JCO Clin Cancer Inform. 2022 Feb.

. 2022 Feb:6:e2100171.

doi: 10.1200/CCI.21.00171.

Authors

Carlos H Barcenas¹, Juhee Song, Rashmi K Murthy¹, Akshara S Raghavendra¹, Yisheng Li¹, Limin Hsu¹, Robert W Carlson¹, Debu Tripathy¹, Gabriel N Hortobagyi¹

Affiliation

¹ Carlos H. Barcenas, MD, MS, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; Juhee Song, PhD, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX; Rashmi K. Murthy, MD, MBE and Akshara S. Raghavendra, MD, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; Yisheng Li, PhD, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX; Limin Hsu, MS, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; Robert W. Carlson, MD, National Comprehensive Cancer Network (NCCN), Plymouth Meeting, PA, Department of Medicine, Division of Medical Oncology, Stanford University Medical Center, Stanford, CA; and Debu Tripathy, MD and Gabriel N. Hortobagyi, MD, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

PMID: 35175860
DOI: 10.1200/CCI.21.00171

No abstract available

PubMed Disclaimer

Conflict of interest statement

Carlos H. BarcenasSpeakers' Bureau: Genomic HealthResearch Funding: Puma Biotechnology (Inst) Rashmi K. MurthyHonoraria: Puma Biotechnology, Genentech, Seattle Genetics, Novartis, AstraZenecaConsulting or Advisory Role: Genentech/Roche, Puma Biotechnology, Seattle Genetics, AstraZeneca, Novartis, Pfizer, SanofiResearch Funding: Genentech/Roche (Inst), Daiichi Sankyo (Inst), Pfizer (Inst), EMD Serono (Inst), Seattle Genetics (Inst), AstraZeneca (Inst)Travel, Accommodations, Expenses: Seattle Genetics, Genentech Robert W. CarlsonEmployment: Flatiron Health (I)Patents, Royalties, Other Intellectual Property: Patents related to inventions as an employee of NCCNOther Relationship: National Comprehensive Cancer Network Debu TripathyConsulting or Advisory Role: Novartis, Pfizer, GlaxoSmithKline, Genomic Health, AstraZeneca, OncoPepResearch Funding: Novartis (Inst), Polyphor (Inst)Travel, Accommodations, Expenses: Novartis, AstraZeneca Gabriel N. HortobagyiConsulting or Advisory Role: NovartisResearch Funding: Novartis (Inst)Travel, Accommodations, Expenses: NovartisNo other potential conflicts of interest were reported.

Comment on

Prognostic Model for De Novo and Recurrent Metastatic Breast Cancer.
Barcenas CH, Song J, Murthy RK, Raghavendra AS, Li Y, Hsu L, Carlson RW, Tripathy D, Hortobagyi GN. Barcenas CH, et al. JCO Clin Cancer Inform. 2021 Aug;5:789-804. doi: 10.1200/CCI.21.00020. JCO Clin Cancer Inform. 2021. PMID: 34351787 Free PMC article.
Systematic Bias in Medical Algorithms: To Include or Not Include Discriminatory Demographic Information?
Pfob A, Sidey-Gibbons C. Pfob A, et al. JCO Clin Cancer Inform. 2022 Feb;6:e2100146. doi: 10.1200/CCI.21.00146. JCO Clin Cancer Inform. 2022. PMID: 35175859 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Reply to A. Pfob and C. Sidey-Gibbons

Affiliation

Reply to A. Pfob and C. Sidey-Gibbons

Authors

Affiliation

Conflict of interest statement

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical